2nd Quarter - Report
BROYDRICK & ASSOCIATES for TONIX PHARMACEUTICALS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$20,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 18, 2026 | $20,000 | Replaced |
| 2nd Quarter - Report | Jul 18, 2026 | $20,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Funding new drug for PTSD and COVID 19, BARDA appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM B BROYDRICK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.